US HB4393 | 2019-2020 | 116th Congress
Status
Spectrum: Strong Partisan Bill (Democrat 37-3)
Status: Introduced on September 18 2019 - 25% progression, died in committee
Action: 2019-09-19 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on September 18 2019 - 25% progression, died in committee
Action: 2019-09-19 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]
Summary
Allows state Medicaid programs to cover DNA sequencing clinical services for certain individuals. Specifically, states may cover such services for individuals under the age of 21 (or a lower age, if the state chooses) and for former foster youth under the age of 26 who (1) have been referred or admitted to a pediatric intensive care unit and seen by a medical specialist for a chronic or undiagnosed disease, and (2) are suspected by a medical specialist to have a pediatric-onset genetic disease. The Centers for Medicare & Medicaid Services may award grants to assist states in developing plans to cover such services. Additionally, the National Academy of Medicine must study the effects of genetic and genomic testing and ways to expand health insurance coverage of such services, including under Medicare and Medicaid.
Title
Advancing Access to Precision Medicine Act
Sponsors
Rep. Eric Swalwell [D-CA] | Rep. Brian Fitzpatrick [R-PA] | Rep. Ruben Gallego [D-AZ] | Rep. Harley Rouda [D-CA] |
Rep. Eleanor Norton [D-DC] | Rep. Jamie Raskin [D-MD] | Rep. Donald Payne [D-NJ] | Rep. Joseph Morelle [D-NY] |
Rep. Darren Soto [D-FL] | Rep. Mo Brooks [R-AL] | Rep. Peter DeFazio [D-OR] | Rep. Gwen Moore [D-WI] |
Rep. G. Butterfield [D-NC] | Rep. David Trone [D-MD] | Rep. Bobby Rush [D-IL] | Rep. Bonnie Coleman [D-NJ] |
Rep. Jackie Speier [D-CA] | Rep. Alcee Hastings [D-FL] | Rep. Ted Lieu [D-CA] | Rep. Josh Harder [D-CA] |
Rep. Julia Brownley [D-CA] | Rep. John Garamendi [D-CA] | Rep. Donald McEachin [D-VA] | Rep. Brad Sherman [D-CA] |
Rep. Suzanne Bonamici [D-OR] | Rep. Terri Sewell [D-AL] | Rep. Jennifer Wexton [D-VA] | Rep. Robin Kelly [D-IL] |
Rep. Frederica Wilson [D-FL] | Rep. Marc Veasey [D-TX] | Rep. Madeleine Dean [D-PA] | Rep. Elaine Luria [D-VA] |
Rep. Karen Bass [D-CA] | Rep. Ro Khanna [D-CA] | Rep. Yvette Clarke [D-NY] | Rep. Susan Wild [D-PA] |
Rep. Mark Green [R-TN] | Rep. Cindy Axne [D-IA] | Rep. James McGovern [D-MA] | Rep. Susan Davis [D-CA] |
History
Date | Chamber | Action |
---|---|---|
2019-09-19 | House | Referred to the Subcommittee on Health. |
2019-09-18 | House | Referred to the House Committee on Energy and Commerce. |
2019-09-18 | House | Introduced in House |
Same As/Similar To
SB3116 (Related) 2019-12-19 - Read twice and referred to the Committee on Finance. (Sponsor introductory remarks on measure: CR S7211)
Subjects
Birth defects
Cancer
Cardiovascular and respiratory health
Congressional oversight
Digestive and metabolic diseases
Genetics
Government studies and investigations
Health
Health care coverage and access
Health care quality
Health personnel
Health programs administration and funding
Health promotion and preventive care
Hospital care
Medicaid
Medical research
Medical tests and diagnostic methods
Neurological disorders
State and local finance
State and local government operations
Cancer
Cardiovascular and respiratory health
Congressional oversight
Digestive and metabolic diseases
Genetics
Government studies and investigations
Health
Health care coverage and access
Health care quality
Health personnel
Health programs administration and funding
Health promotion and preventive care
Hospital care
Medicaid
Medical research
Medical tests and diagnostic methods
Neurological disorders
State and local finance
State and local government operations
US Congress State Sources
Type | Source |
---|---|
Summary | https://www.congress.gov/bill/116th-congress/house-bill/4393/all-info |
Text | https://www.congress.gov/116/bills/hr4393/BILLS-116hr4393ih.pdf |